STOCK TITAN

ADAR1 entities hold ~9–10% of Equillium (EQ) as of Mar 31, 2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Equillium, Inc. Schedule 13G/A: ADAR1-related entities and Daniel Schneeberger report indirect beneficial ownership of common stock as of March 31, 2026. ADAR1 Capital Management, LLC is shown with 6,603,754 shares (9.9%); ADAR1 Capital Management GP, LLC with 6,306,184 shares (9.5%). The filing cites 63,226,556 shares outstanding as of March 31, 2026 per the issuer's Form 10-Q. The cover disclosures list constituent holdings and 2,877,095 shares underlying prefunded warrants, and note 557,415 prefunded-warrant shares excluded due to a 9.99% beneficial ownership limitation. The filing states these holdings are indirect, reflecting ADAR1’s roles as investment manager, general partner, and Mr. Schneeberger’s manager/control-person status.

Positive

  • None.

Negative

  • None.

Insights

ADAR1 group holds just under double‑digit stakes in Equillium based on March 31, 2026 outstanding shares.

Documented holdings show 6,603,754 shares (9.9%) for ADAR1 Capital Management and 6,306,184 shares (9.5%) for ADAR1 Capital Management GP, based on 63,226,556 shares outstanding. The positions include common stock and substantial prefunded warrant exposure of 2,877,095 shares.

Ownership is described as indirect through managed funds and SPVs, and the filing notes a 9.99% beneficial ownership limitation that excludes 557,415 prefunded‑warrant shares. Subsequent filings or conversions could change reported percentages if and when exchanges occur.

ADAR1 Capital Management holdings 6,603,754 shares reported as 9.9% of class as of March 31, 2026
ADAR1 Capital Management GP holdings 6,306,184 shares reported as 9.5% of class as of March 31, 2026
Shares outstanding used 63,226,556 shares outstanding as of March 31, 2026 per issuer Form 10‑Q
Prefunded warrants included 2,877,095 shares shares underlying prefunded warrants included in reported holdings
Prefunded warrants excluded 557,415 shares excluded due to 9.99% beneficial ownership limitation
prefunded warrants financial
"2,877,095 shares of Common Stock underlying prefunded warrants held by ADAR1 Partners"
Prefunded warrants are a security that gives the holder the right to convert the warrant into a share after paying a very small remaining amount because almost the full purchase price was paid upfront. They matter to investors because exercising them increases the company’s outstanding shares (dilution) and can provide immediate cash to the issuer while allowing holders to bypass ownership limits or simplify timing, similar to buying a nearly-complete gift card that only needs a tiny top-up to use.
beneficial ownership limitation regulatory
"exchange and exercise of which are subject to 9.99% beneficial ownership limitations"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Schedule 13G/A regulatory
"This Schedule is being filed on behalf of each of the following persons"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
indirect beneficially own regulatory
"may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





29446K106

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Includes (i) 2,786,136 shares of common stock, par value $0.0001 per share ("Common Stock") held by ADAR1 Partners, LP, (ii) 404,699 shares of Common Stock held by Spearhead Insurance Solutions IDF, LLC, (iii) 533,742 shares of Common Stock held by ADAR1 SPV I, LP, (iv) 2,082 shares of Common Stock held by other separately managed accounts and (v) 2,877,095 shares of Common Stock underlying prefunded warrants held by ADAR1 Partners, LP, ADAR1 SPV I, LP and Spearhead Insurance Solutions IDF, LLC as of March 31, 2026. Excludes 557,415 shares of Common Stock underlying prefunded warrants held by ADAR1 Partners, LP, ADAR1 SPV I, LP and Spearhead Insurance Solutions IDF, LLC, the exchange and exercise of which are subject to 9.99% beneficial ownership limitations. As the investment manager of ADAR1 Partners, LP and ADAR1 SPV I, LP and as the sub-advisor of Spearhead Insurance Solutions IDF, LLC and the separately managed accounts referenced above, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP; Spearhead Insurance Solutions IDF, LLC; ADAR1 SPV I, LP and the separately managed accounts. Based on 63,226,556 shares of Common Stock of Equillium Inc. (the "Issuer") outstanding as of March 31, 2026, reported in the Issuer's Form 10Q for the quarterly period ended March 31, 2026, filed with the Securities and Exchange Commission on May 13, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes (i) 2,786,136 shares of common stock, par value $0.0001 per share ("Common Stock") held by ADAR1 Partners, LP, (ii) 533,742 shares of Common Stock held by ADAR1 SPV I, LP and (iii) 2,986,306 shares of Common Stock underlying prefunded warrants held by ADAR1 Partners, LP and ADAR1 SPV I, LP as of March 31, 2026. As the general partner of ADAR1 Partners, LP and ADAR1 SPV I, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and ADAR1 SPV I, LP. Based on 63,226,556 shares of Common Stock of Equillium Inc. (the "Issuer") outstanding as of March 31, 2026, reported in the Issuer's Form 10Q for the quarterly period ended March 31, 2026, filed with the Securities and Exchange Commission on May 13, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes (i) 2,786,136 shares of common stock, par value $0.0001 per share ("Common Stock") held by ADAR1 Partners, LP, (ii) 404,699 shares of Common Stock held by Spearhead Insurance Solutions IDF, LLC, (iii) 533,742 shares of Common Stock held by ADAR1 SPV I, LP, (iv) 2,082 shares of Common Stock held by other separately managed accounts and (v) 2,877,095 shares of Common Stock underlying prefunded warrants held by ADAR1 Partners, LP, ADAR1 SPV I, LP and Spearhead Insurance Solutions IDF, LLC as of March 31, 2026. Excludes 557,415 shares of Common Stock underlying prefunded warrants held by ADAR1 Partners, LP, ADAR1 SPV I, LP and Spearhead Insurance Solutions IDF, LLC, the exchange and exercise of which are subject to 9.99% beneficial ownership limitations. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP; Spearhead Insurance Solutions IDF, LLC; ADAR1 SPV I, LP; and the separately managed accounts referenced above. Based on 63,226,556 shares of Common Stock of Equillium Inc. (the "Issuer") outstanding as of March 31, 2026, reported in the Issuer's Form 10Q for the quarterly period ended March 31, 2026, filed with the Securities and Exchange Commission on May 13, 2026.


SCHEDULE 13G



ADAR1 Capital Management, LLC
Signature:/s/ Daniel Schneeberger
Name/Title:Daniel Schneeberger, Manager
Date:05/15/2026
ADAR1 Capital Management GP, LLC
Signature:/s/ Daniel Schneeberger
Name/Title:Daniel Schneeberger, Manager
Date:05/15/2026
Daniel Schneeberger
Signature:/s/ Daniel Schneeberger
Name/Title:Daniel Schneeberger, in his individual capacity
Date:05/15/2026

FAQ

What stake does ADAR1 Capital Management report in Equillium (EQ)?

ADAR1 Capital Management reports 6,603,754 shares, or 9.9%, of Equillium common stock as of March 31, 2026, including common stock and prefunded‑warrant exposure described in the filing.

How many shares outstanding does Equillium report used in the ownership calculation?

The filing references 63,226,556 shares outstanding as of March 31, 2026, drawn from Equillium's Form 10‑Q for the quarter ended March 31, 2026.

Do the reported holdings include prefunded warrants?

Yes. The cover pages list 2,877,095 shares underlying prefunded warrants included in the reported holdings and note 557,415 prefunded‑warrant shares are excluded due to a 9.99% beneficial ownership limitation.

Why are the holdings described as indirect for ADAR1 and Mr. Schneeberger?

The filing states ADAR1 entities act as investment manager, general partner, or sub‑advisor to funds and accounts, so ADAR1 Capital Management and Mr. Schneeberger may be deemed to indirectly beneficially own the securities held by those entities.

What percent does ADAR1 Capital Management GP, LLC report owning?

ADAR1 Capital Management GP, LLC reports 6,306,184 shares, or 9.5%, of Equillium common stock as of March 31, 2026, per the Schedule 13G/A cover data.